Oura is buying its way from tracking health to treating it. The smart ring maker announced on Tuesday that it has entered a definitive agreement to acquire Counsel Health, an AI-native primary care company, for $625 million in cash — pairing the biometric data its ring collects around the clock with medical AI and on-demand physicians inside the Oura App.
November 10, 2026 — Why it matters: this is one of the largest bets yet that the future of consumer health is a wearable that does not just flag a problem, but connects you to a doctor about it within minutes.
What Oura is buying
Counsel Health was founded and built by physicians and AI researchers, and its model puts AI first without cutting doctors out. Members start by chatting with Counsel’s medical AI, which draws on connected medical records, prior interactions, clinical guidelines and — with Oura — continuous biometric data. At any point the conversation can escalate to a board-certified Counsel physician, who can provide a diagnosis, prescriptions and referrals.
Under the surface, Counsel runs what it calls a clinical AI harness: specialized agents handle tasks such as medical history-taking, guideline retrieval, records review and emergency detection, each evaluated for safety and quality and improved with physician feedback. Its doctors work from a “Clinician Cockpit” that synthesizes a patient’s record and health trends into context-aware suggestions. Counsel sells that service today through health plans, health systems, employers and consumer health organizations, and Oura says it will keep serving those enterprise partners after the deal closes — opening Counsel’s care model to patients well beyond Oura’s own member base.
The deal and the numbers behind it
Oura is paying $625 million in cash, subject to purchase price adjustments, and expects the transaction to close before the end of the calendar year, subject to customary closing conditions. Counsel had previously disclosed $36 million in funding, according to STAT, which makes the price a striking outcome for a clinical AI startup — and a statement about how valuable a physician-supervised AI care layer has become.
Oura announced the deal alongside record results. For its fiscal fourth quarter, ended September 30, 2026, revenue grew 153 percent year over year to $533 million, with $87 million of Adjusted EBITDA. Fiscal 2026 revenue was approximately $1.75 billion, up 92 percent. Oura flags those figures as preliminary and unaudited. The company also points to an existing partnership as proof the combination works: among members already using Counsel, more than 90 percent of those surveyed said their Oura data helped them get better care, and members who saw a Counsel physician rated the experience 4.6 out of 5 — both figures reported by Oura itself.
Why it matters
Wearables have spent a decade getting better at measurement while leaving the hardest part — what to do about a worrying reading — to the user. Oura is trying to close that loop: the ring notices, the AI triages, and a human physician decides, all in one app. That is the “24-7 doctor in your pocket” pitch Oura CEO Tom Hale made in the announcement, and it lands just over a month after Oura delayed its own IPO plans amid market uncertainty, per STAT. Instead of going public, it is spending $625 million to become a care company, not just a sensor company. For subscribers, the test to watch is the same one we apply to every AI health claim: the AI handles the conversation, but clinical decisions stay with physicians — and whether regulators and patients stay comfortable as that model scales to millions of members.
Frequently asked questions
How much is Oura paying for Counsel Health?
$625 million in cash, subject to purchase price adjustments. The deal is expected to close before the end of the calendar year, subject to customary closing conditions.
What does Counsel Health actually do?
It is an AI-native primary care service. Patients chat first with medical AI, then can escalate to a board-certified physician within minutes for diagnosis, prescriptions and referrals. It also sells through health plans, health systems and employers.
Will an AI be making medical decisions?
Based on the companies’ description, no: specialized AI agents handle history-taking, guideline retrieval and records review, while Counsel’s in-house physicians remain in the loop for clinical decisions.
What changes for Oura Ring owners?
The plan is for members to start from an Oura insight or a chat inside the Oura App and reach care — from quick questions to chronic care and referrals — without leaving it. Counsel will also keep serving its existing enterprise partners.
Sources: Business Wire (ŌURA announcement), Reuters, STAT, The Wall Street Journal